HomeJAGSNPHARM • NSE
add
Jagsonpal Pharmaceuticals Ltd
Previous close
₹239.31
Day range
₹231.55 - ₹267.00
Year range
₹110.00 - ₹328.04
Market cap
16.18B INR
Avg Volume
94.58K
P/E ratio
30.22
Dividend yield
0.85%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 740.25M | 56.72% |
Operating expense | 340.87M | 39.08% |
Net income | 319.90M | 707.22% |
Net profit margin | 43.22 | 415.14% |
Earnings per share | — | — |
EBITDA | 135.48M | 324.62% |
Effective tax rate | 17.28% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 778.45M | -30.24% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 1.97B | — |
Shares outstanding | 67.49M | — |
Price to book | 8.04 | — |
Return on assets | — | — |
Return on capital | 16.22% | — |
Cash Flow
Net change in cash
(INR) | Dec 2024info | Y/Y change |
---|---|---|
Net income | 319.90M | 707.22% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1978
Website
Employees
1,025